Clinical Trials Directory

Trials / Completed

CompletedNCT05684861

Serum TWEAK Levels in Acne Vulgaris

Serum TWEAK Levels in Acne Vulgaris Patients Treated With Oral Isotretinoin

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
150 (actual)
Sponsor
South Valley University · Academic / Other
Sex
All
Age
10 Years – 60 Years
Healthy volunteers
Accepted

Summary

Evaluate the serum level of TWEAK in patients with AV and their relations before and after treatment with isotretinoin.

Detailed description

Acne vulgaris is a chronic inflammatory disease of the pilosebaceous follicles, characterized by comedones, papules, pustules, cysts, nodules, and occasionally scars. Its pathogenesis includes follicular hyperkeratinization, sebaceous hypersecretion due to androgen stimulation, follicular colonization by Propionibacterium acnes, immune and inflammatory responses. It affects the face, anterior chest, and upper back . Inflammation is regarded as a key component in the pathogenesis of acne . An increase in the activity of the pro inflammatory cytokine, interleukin (IL) 1, is observed before the beginning of hyperproliferation around the uninvolved follicles and is thought to trigger the activation of keratinocyte proliferation. Nuclear factor kappa beta (NF κβ) regulated mRNA gene levels of the cytokines tumour necrosis factor (TNF) α, IL 1 β, IL 8 and IL 10 levels also affected. Isotretinoin (13-cis retinoic acid) is a synthetic analog of vitamin A. Its oral form is prescribed for severe cases which are resistant to other treatments. Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) belongs to the TNF superfamily. It has an important role in the regulation of cell growth, apoptosis, angiogenesis, and immune reactions.

Conditions

Interventions

TypeNameDescription
DRUGIsotretinoinsystemic isotretinoin was given to all 90 patients , dose was prescribed according to weight for 3 months
DIAGNOSTIC_TESTELISA Assays of Serum TWEAK.: From each subject, 5mL of blood was collected into vacutainers before and after treatment with isotretinoin. The blood samples were centrifuged at 3000g for 10 min at a temperature of 4°C, then . Quantitative determinations for serum TWEAK were achieved using the corresponding commercially available ELISA kit supplied by the AssayMax

Timeline

Start date
2022-01-01
Primary completion
2022-12-20
Completion
2023-01-01
First posted
2023-01-13
Last updated
2023-01-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05684861. Inclusion in this directory is not an endorsement.